Eli Lilly's Alzheimer's Drug Gets FDA Approval. Here's Why Stocks Won't Take Off.

Eli Lilly’s Alzheimer’s Drug Gets FDA Approval. Here’s Why Stocks Won’t Take Off.

Eli Lilly (NYSE: LLY) received good news from regulators last week: Its Alzheimer’s treatment received the green light from the […]